nipocalimab

Neurology news roundup: seven cerebral palsy drug candidates are flagged as ones to watch, a gluten-free diet is reported to improve cognition and quality of life in Parkinson's disease, and new real-world data covers treatment transitions to nipocalimab in generalized myasthenia gravis. The items span pediatrics, nutrition, and antibody-based therapy for autoimmune neuromuscular disease.